{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:32:39Z","timestamp":1793295159680,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:00:00Z","timestamp":1644624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Tuberculosis (TB) is a communicable disease remains a major global health problem and the leading cause of death from a single infectious agent. Even though many of the WHO recommended TB control strategies were implemented; there is still a major gap in TB case detection and treatment. This study aimed to determine the prevalence of\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      among presumptive TB patients in Gedeo Zone, Southern Ethiopia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A cross-sectional study was conducted on 384\u00a0TB suspected patients in Gedeo Zone from February to July 2021. Data were collected using a pretested structured questionnaire. Laboratory examination was processed using Xpert-MTB\/RIF assay. Data entry was made using Epi info version 7 and analyzed by SPSS version 24. Logistic regression models were used to determine the risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 384 study participants suspected with TB,\n                      <jats:italic>M. tuberculosis<\/jats:italic>\n                      was isolated from 103 giving an overall prevalence of 26.8%. Males (AOR)\u2009=\u20091.95; 95% CI 1.56\u20132.65,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01) were more likely to develop TB than females. Study participants who were illiterate (AOR 2.10; 95% CI 1.17\u20132.51,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.014) were more likely to develop TB than the educated ones. Cigarette smokers (AOR 2.89; 95% CI 2.10\u20133.84,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01), khat chewers (AOR 2.86; 95% CI 1.28\u20133.79,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01), vaccination (AOR 0.52; 95% CI 0.21\u20130.88,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.02), close contact (AOR 3.42; 95% CI 2.24\u20134.50,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.01) and being positive for HIV (AOR 2.01; 95% CI 1.07\u20133.52, 0.01) were more likely to develop TB.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Despite implementation of national and international TB control strategies, TB still remains one of the major public health problems in the country especially in the study area. The high prevalence of MTB was reported different risk groups. Early case detection and management of TB should be given special attention to strengthen and an appropriate control and prevention methods to reduce the emergence and increasing of MTB cases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-022-00650-x","type":"journal-article","created":{"date-parts":[[2022,2,12]],"date-time":"2022-02-12T00:02:44Z","timestamp":1644624164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The prevalence of Mycobacterium tuberculosis using Gene Xpert among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia"],"prefix":"10.1186","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7083-7725","authenticated-orcid":false,"given":"Kuma","family":"Diriba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemechu","family":"Churiso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,12]]},"reference":[{"issue":"3","key":"650_CR1","first-page":"153","volume":"16","author":"M Khan","year":"2019","unstructured":"Khan M, Raja Z, Ahmed H, Rauf A. A pattern of tuberculosis infection an overview. Pak J Biotechnol. 2019;16(3):153\u201361.","journal-title":"Pak J Biotechnol"},{"key":"650_CR2","volume-title":"Global status report on alcohol and health 2018","author":"Organization WH","year":"2019","unstructured":"Organization WH. Global status report on alcohol and health 2018. Geneva: World Health Organization; 2019."},{"key":"650_CR3","volume-title":"Tracking universal health coverage: first global monitoring report","author":"Organization WH","year":"2015","unstructured":"Organization WH. Tracking universal health coverage: first global monitoring report. Geneva: World Health Organization; 2015."},{"key":"650_CR4","volume-title":"Global tuberculosis report 2013","author":"Organization WH","year":"2013","unstructured":"Organization WH. Global tuberculosis report 2013. Geneva: World Health Organization; 2013."},{"key":"650_CR5","unstructured":"Organization WH. World Health Organization global tuberculosis report 2017 (WHO\/HTM\/TB\/2017.23). World Health Organization, Geneva, Switzerland. 2017. http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf."},{"issue":"2","key":"650_CR6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3329\/jhpn.v28i2.4879","volume":"28","author":"K Zaman","year":"2010","unstructured":"Zaman K. Tuberculosis: a global health problem. J Health Popul Nutr. 2010;28(2):111.","journal-title":"J Health Popul Nutr"},{"issue":"6","key":"650_CR7","doi-asserted-by":"crossref","first-page":"e38816","DOI":"10.1371\/journal.pone.0038816","volume":"7","author":"EL Korenromp","year":"2012","unstructured":"Korenromp EL, Glaziou P, Fitzpatrick C, Floyd K, Hosseini M, Raviglione M, et al. Implementing the global plan to stop TB, 2011\u20132015\u2013optimizing allocations and the global fund\u2019s contribution: a scenario projections study. PLoS ONE. 2012;7(6):e38816.","journal-title":"PLoS ONE"},{"issue":"9979","key":"650_CR8","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","volume":"385","author":"M Uplekar","year":"2015","unstructured":"Uplekar M, Weil D, Lonnroth K, Jaramillo E, Lienhardt C, Dias H. WHO\u2019s Global. TB Programme. WHO\u2019s new end TB strategy. Lancet. 2015;385(9979):1799\u2013801.","journal-title":"Lancet"},{"issue":"2","key":"650_CR9","first-page":"7","volume":"8","author":"S Nimbarte","year":"2009","unstructured":"Nimbarte S, Deshmukh P, Mehendale A, Garg B. Effect of duration of cough (\u2265 3 weeks vs \u2265 2 weeks) on yield of sputum positive tuberculosis cases and laboratory load. Online J Health Allied Sci. 2009;8(2):7.","journal-title":"Online J Health Allied Sci"},{"issue":"7","key":"650_CR10","first-page":"e699730","volume":"8","author":"J Singh","year":"2013","unstructured":"Singh J, Sankar MM, Kumar S, Gopinath K, Singh N, Mani K, et al. Incidence and prevalence of tuberculosis among household contacts of pulmonary tuberculosis patients in a peri-urban population of South Delhi, India. PLoS ONE. 2013;8(7):e699730.","journal-title":"PLoS ONE"},{"key":"650_CR11","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6738532","author":"A Adane","year":"2020","unstructured":"Adane A, Damena M, Weldegebreal F, Mohammed H. Prevalence and associated factors of tuberculosis among adult household contacts of smear positive pulmonary tuberculosis patients treated in public health facilities of Haramaya district, Oromia region, eastern Ethiopia. Tuberc Res Treat. 2020. https:\/\/doi.org\/10.1155\/2020\/6738532.","journal-title":"Tuberc Res Treat"},{"key":"650_CR12","first-page":"1","volume":"9","author":"B Omotowo","year":"2012","unstructured":"Omotowo B, Ekwueme O, Aghaji M. M. Tuberculosis control mechanisms and contact tracing: knowledge and practice among TB patients at DOT centres is Southeast Nigeria. Sci Rep. 2012;9:1.","journal-title":"Sci Rep"},{"issue":"4","key":"650_CR13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1164\/rccm.200212-1483OC","volume":"168","author":"C Lienhardt","year":"2003","unstructured":"Lienhardt C, Fielding K, Sillah J, Tunkara A, Donkor S, Manneh K, et al. Risk factors for tuberculosis infection in sub-Saharan Africa: a contact study in the Gambia. Am J Respir Crit Care Med. 2003;168(4):448\u201355.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"650_CR14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4081\/monaldi.2005.656","volume":"63","author":"P Davies","year":"2005","unstructured":"Davies P. Risk factors for tuberculosis. Monaldi Arch Chest Dis. 2005;63(1):37\u201346.","journal-title":"Monaldi Arch Chest Dis"},{"issue":"7533","key":"650_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1136\/bmj.38684.687940.80","volume":"332","author":"R Coker","year":"2006","unstructured":"Coker R, McKee M, Atun R, Dimitrova B, Dodonova E, Kuznetsov S, et al. Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ. 2006;332(7533):85\u20137.","journal-title":"BMJ"},{"key":"650_CR16","first-page":"2006","volume-title":"Ethiopia demographic and health survey","author":"EYs b\u0101la\u015bel\u1e6d\u0101n","year":"2005","unstructured":"b\u0101la\u015bel\u1e6d\u0101n EYs, Macro O. Ethiopia demographic and health survey. Addis Ababa: Central statistical authority; 2005. p. 2006."},{"key":"650_CR17","volume-title":"National consolidated guidelines for comprehensive HIV prevention, care and treatment","author":"E FMoHo","year":"2020","unstructured":"FMoHo E. National consolidated guidelines for comprehensive HIV prevention, care and treatment. Geneva: World Health Organization; 2020."},{"key":"650_CR18","doi-asserted-by":"crossref","first-page":"205031212110455","DOI":"10.1177\/20503121211045541","volume":"9","author":"DB Andarge","year":"2021","unstructured":"Andarge DB, Anticho TL, Jara GM, Ali MM. Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare general hospital South Ethiopia. SAGE Open Med. 2021;9:20503121211045540.","journal-title":"SAGE Open Med"},{"issue":"1","key":"650_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13104-016-2345-3","volume":"10","author":"W Mulu","year":"2017","unstructured":"Mulu W, Abera B, Yimer M, Hailu T, Ayele H, Abate D. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos referral hospital, Ethiopia: a cross-sectional study. BMC Res Notes. 2017;10(1):1\u20138.","journal-title":"BMC Res Notes"},{"key":"650_CR20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.11604\/pamj.2014.19.43.2757","volume":"19","author":"L Tahiri","year":"2014","unstructured":"Tahiri L, Azzouzi H, Squalli G, Abourazzak F, Harzy T. Celiac disease causing severe osteomalacia: an association still present in Morocco! Pan Afr Med J. 2014;19:43.","journal-title":"Pan Afr Med J"},{"key":"650_CR21","volume-title":"Surveillance of rifampicin resistance with GeneXpert MTB\/RIF in the national reference laboratory for tuberculosis at the Institut Pasteur in Bangui, 2015\u20132017 Open forum infectious diseases","year":"2019","unstructured":"Farra A, Manirakiza A, Yambiyo BM, Zandanga G, Lokoti B, Berlioz-Arthaud A, et al editors. Surveillance of rifampicin resistance with GeneXpert MTB\/RIF in the national reference laboratory for tuberculosis at the Institut Pasteur in Bangui, 2015\u20132017 Open forum infectious diseases. Oxford: Oxford University Press US; 2019."},{"key":"650_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmni.2015.09.001","volume":"8","author":"A Dagnra","year":"2015","unstructured":"Dagnra A, Mlaga K, Adjoh K, Kadanga E, Disse K, Adekambi T. Prevalence of multidrug-resistant tuberculosis cases among HIV-positive and HIV-negative patients eligible for retreatment regimen in Togo using GeneXpert MTB\/RIF. New Microb New Infect. 2015;8:24\u20137.","journal-title":"New Microb New Infect"},{"issue":"3","key":"650_CR23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s40121-020-00368-5","volume":"10","author":"AG Wasihun","year":"2021","unstructured":"Wasihun AG, Hailu GG, Dejene TA. Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and associated risk actors among pulmonary presumptive TB patients in eastern amhara, Ethiopia: 2015\u20132019. Infect Dis Ther. 2021;10(3):1299\u2013308.","journal-title":"Infect Dis Ther"},{"key":"650_CR24","doi-asserted-by":"publisher","DOI":"10.4314\/ejhd.v22i2.10075","author":"K Desta","year":"2008","unstructured":"Desta K, Asrat D, Lemma E, Gebeyehu M, Feleke B. Drug susceptibility of Mycobacterium tuberculosis isolates from smear negative pulmonary tuberculosis patients, Addis Ababa, Ethiopia. Ethiop J Health Dev. 2008. https:\/\/doi.org\/10.4314\/ejhd.v22i2.10075.","journal-title":"Ethiop J Health Dev"},{"issue":"11","key":"650_CR25","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(11)70167-0","volume":"11","author":"MP Nicol","year":"2011","unstructured":"Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, et al. Accuracy of the Xpert MTB\/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis. 2011;11(11):819\u201324.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"650_CR26","first-page":"32","volume":"45","author":"C-H Kim","year":"2015","unstructured":"Kim C-H, Hyun IG, Hwang YI, Kim D-G, Lee CY, Lee MG, et al. Identification of Mycobacterium tuberculosis and rifampin resistance in clinical specimens using the Xpert MTB\/RIF assay. Ann Clin Lab Sci. 2015;45(1):32\u20138.","journal-title":"Ann Clin Lab Sci"},{"issue":"1","key":"650_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-4-1","volume":"4","author":"L Yin","year":"2007","unstructured":"Yin L, Qin G, Qian H-Z, Zhu Y, Hu W, Zhang L, et al. Continued spread of HIV among injecting drug users in southern Sichuan province China. Harm Reduct J. 2007;4(1):1\u20137.","journal-title":"Harm Reduct J"},{"issue":"1","key":"650_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-016-3210-y","volume":"16","author":"SD Hamusse","year":"2016","unstructured":"Hamusse SD, Teshome D, Hussen MS, Demissie M, Lindtj\u00f8rn B. Primary and secondary anti-tuberculosis drug resistance in Hitossa district of Arsi zone, Oromia regional state Central Ethiopia. BMC Public Health. 2016;16(1):1\u201310.","journal-title":"BMC Public Health"},{"issue":"4","key":"650_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5365\/wpsar.2017.8.4.011","volume":"9","author":"K Know","year":"2018","unstructured":"Know K, Yadav R, Denholm J, Sawyer S, Graham S. Tuberculosis among children, adolescents and young adults in the Philippines: a surveillance report. West Pac Surveill Response J. 2018;9(4):16.","journal-title":"West Pac Surveill Response J"},{"issue":"4","key":"650_CR30","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1371\/journal.pone.0152694","volume":"11","author":"A Rahman","year":"2016","unstructured":"Rahman A, Sahrin M, Afrin S, Earley K, Ahmed S, Rahman SM, et al. Comparison of Xpert MTB\/RIF assay and GenoType MTBDR plus DNA probes for detection of mutations associated with rifampicin resistance in Mycobacterium tuberculosis. PLoS ONE. 2016;11(4):2694.","journal-title":"PLoS ONE"},{"issue":"1","key":"650_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-5-1","volume":"5","author":"G Abebe","year":"2012","unstructured":"Abebe G, Abdissa K, Abdissa A, Apers L, Agonafir M, de Jong BC, et al. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia. BMC Res Notes. 2012;5(1):1\u20136.","journal-title":"BMC Res Notes"},{"issue":"1","key":"650_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4717-5","volume":"20","author":"HZ Sa\u2019ed","year":"2020","unstructured":"Sa\u2019ed HZ, Al-Jabi SW. Mapping the situation of research on coronavirus disease-19 (COVID-19) a preliminary bibliometric analysis during the early stage of the outbreak. BMC Infect Dis. 2020;20(1):1\u20138.","journal-title":"BMC Infect Dis"},{"issue":"462","key":"650_CR33","first-page":"266","volume":"5","author":"GM Hordofa","year":"2012","unstructured":"Hordofa GM. Multi-drug resistant Mycobacterium tuberculosis and. BMC Res Notes. 2012;5(462):266.","journal-title":"BMC Res Notes"},{"issue":"2","key":"650_CR34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/phmj.phmj_15_17","volume":"11","author":"EP Odum","year":"2017","unstructured":"Odum EP, Udi EO. Evaluation of cardiovascular risk factors in patients with chronic kidney disease. Port Harcourt Med J. 2017;11(2):60.","journal-title":"Port Harcourt Med J"},{"issue":"3","key":"650_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.11648\/j.cmr.20150403.13","volume":"4","author":"MW Hordofa","year":"2015","unstructured":"Hordofa MW, Adela TB. Prevalence of Refampcin mono resistant Mycobacterium tuberculosis among suspected cases attending at Yirgalem hospital. Clin Med Res. 2015;4(3):75\u20138.","journal-title":"Clin Med Res"},{"issue":"1","key":"650_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-015-1933-9","volume":"15","author":"K Adane","year":"2015","unstructured":"Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. BMC Public Health. 2015;15(1):1\u20138.","journal-title":"BMC Public Health"},{"issue":"1","key":"650_CR37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/ijmr.IJMR_1029_16","volume":"146","author":"J Bhat","year":"2017","unstructured":"Bhat J, Rao V, Sharma R, Muniyandi M, Yadav R, Bhondley MK. Investigation of the risk factors for pulmonary tuberculosis: a case\u2013control study among Saharia tribe in Gwalior district, Madhya Pradesh, India. Indian J Med Res. 2017;146(1):97.","journal-title":"Indian J Med Res"},{"issue":"4","key":"650_CR38","first-page":"227","volume":"51","author":"G Berhe","year":"2013","unstructured":"Berhe G, Enquselassie F, Aseffa A. Assessment of risk factors for development of active pulmonary tuberculosis in northern part of Ethiopia: a matched case control study. Ethiop Med J. 2013;51(4):227\u201337.","journal-title":"Ethiop Med J"},{"issue":"2","key":"650_CR39","first-page":"105","volume":"39","author":"A Kehinde","year":"2010","unstructured":"Kehinde A, Baba A, Bakare R, Ige O, Gbadeyanka C, Salako A. Risk factors for pulmonary tuberculosis among health-care workers in Ibadan, Nigeria. Afr J Med Med Sci. 2010;39(2):105\u201312.","journal-title":"Afr J Med Med Sci"},{"issue":"4","key":"650_CR40","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1371\/journal.pone.0214235","volume":"14","author":"E Shimeles","year":"2019","unstructured":"Shimeles E, Enquselassie F, Aseffa A, Tilahun M, Mekonen A, Wondimagegn G, et al. Risk factors for tuberculosis: a case\u2013control study in Addis Ababa, Ethiopia. PLoS ONE. 2019;14(4):4235.","journal-title":"PLoS ONE"},{"key":"650_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6207457","author":"SM Gelaw","year":"2016","unstructured":"Gelaw SM. Socioeconomic factors associated with knowledge on tuberculosis among adults in Ethiopia. Tuberc Res Treat. 2016. https:\/\/doi.org\/10.1155\/2016\/6207457.","journal-title":"Tuberc Res Treat"},{"issue":"6","key":"650_CR42","doi-asserted-by":"crossref","first-page":"97","DOI":"10.14745\/ccdr.v40i06a01","volume":"40","author":"G Taylor","year":"2014","unstructured":"Taylor G. Tuberculosis: making progress to stop tuberculosis. Canada Commun Dis Rep. 2014;40(6):97.","journal-title":"Canada Commun Dis Rep"},{"issue":"1","key":"650_CR43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-0500-7-1","volume":"7","author":"B Tulu","year":"2014","unstructured":"Tulu B, Dida N, Kassa Y, Taye B. Smear positive pulmonary tuberculosis and its risk factors among tuberculosis suspect in South East Ethiopia; a hospital based cross-sectional study. BMC Res Notes. 2014;7(1):1\u20136.","journal-title":"BMC Res Notes"},{"issue":"2","key":"650_CR44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4314\/ajid.v8i2.1","volume":"8","author":"E Bigwan","year":"2014","unstructured":"Bigwan E, Ohaeri M, David E, Wakjissa FD, Sheyin Z. Some risk factors associated with acid-alcohol-fast bacilli in patients with suspected pulmonary tuberculosis in jos, central Nigeria. Afr J Infect Dis. 2014;8(2):27\u201330.","journal-title":"Afr J Infect Dis"},{"issue":"4","key":"650_CR45","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.1136\/bmjopen-2015-009058","volume":"6","author":"YM Alemu","year":"2016","unstructured":"Alemu YM, Awoke W, Wilder-Smith A. Determinants for tuberculosis in HIV-infected adults in Northwest Ethiopia: a multicentre case\u2013control study. BMJ Open. 2016;6(4):9058.","journal-title":"BMJ Open"},{"issue":"6","key":"650_CR46","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0962-8479(96)90052-0","volume":"77","author":"M Altet","year":"1996","unstructured":"Altet M, Alcaide J, Plans P, Taberner J, Salto E, Folguera L, et al. Passive smoking and risk of pulmonary tuberculosis in children immediately following infection a case-control study. Tuber Lung Dis. 1996;77(6):537\u201344.","journal-title":"Tuber Lung Dis"},{"issue":"11","key":"650_CR47","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2105\/AJPH.84.11.1750","volume":"84","author":"SE Buskin","year":"1994","unstructured":"Buskin SE, Gale JL, Weiss NS, Nolan CM. Tuberculosis risk factors in adults in king county, Washington, 1988 through 1990. Am J Public Health. 1994;84(11):1750\u20136.","journal-title":"Am J Public Health"},{"issue":"1\u20132","key":"650_CR48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0165-5728(97)00231-2","volume":"83","author":"ML Sopori","year":"1998","unstructured":"Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998;83(1\u20132):148\u201356.","journal-title":"J Neuroimmunol"},{"issue":"7","key":"650_CR49","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/thx.2004.030924","volume":"60","author":"S Den Boon","year":"2005","unstructured":"Den Boon S, Van Lill S, Borgdorff M, Verver S, Bateman E, Lombard C, et al. Association between smoking and tuberculosis infection: a population survey in a high tuberculosis incidence area. Thorax. 2005;60(7):555\u20137.","journal-title":"Thorax"},{"issue":"10","key":"650_CR50","first-page":"980","volume":"7","author":"C Leung","year":"2003","unstructured":"Leung C, Yew W, Chan C, Tam C, Lam C, Chang K, et al. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis. 2003;7(10):980\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"650_CR51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.mehy.2014.02.026","volume":"82","author":"A Alvi","year":"2014","unstructured":"Alvi A, Rizwan M, Sunosi RA, Jerah ABA. Does khat chewing increases the risk of Mycobacterium tuberculosis infection by macrophage immune modulation? Med Hypotheses. 2014;82(6):667\u20139.","journal-title":"Med Hypotheses"},{"issue":"7","key":"650_CR52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1080\/00325481.2018.1510709","volume":"130","author":"M Son","year":"2018","unstructured":"Son M, Park YS, Jung MH, Kang JH, Choi UY. Risk factors for latent tuberculosis infection in children in South Korea. Postgrad Med. 2018;130(7):637\u201343.","journal-title":"Postgrad Med"},{"issue":"Suppl 1","key":"650_CR53","first-page":"45","volume":"43","author":"H Adesokan","year":"2014","unstructured":"Adesokan H, Cadmus E, Adeyemi W, Lawal O, Ogunlade C, Osman E, et al. Prevalence of previously undetected tuberculosis and underlying risk factors for transmission in a prison setting in Ibadan, south-western Nigeria. Afr J Med Med Sci. 2014;43(Suppl 1):45.","journal-title":"Afr J Med Med Sci"},{"issue":"6","key":"650_CR54","doi-asserted-by":"crossref","first-page":"e5934","DOI":"10.1371\/journal.pone.0005934","volume":"4","author":"KT Whelan","year":"2009","unstructured":"Whelan KT, Pathan AA, Sander CR, Fletcher HA, Poulton I, Alder NC, et al. Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A. PLoS ONE. 2009;4(6):e5934.","journal-title":"PLoS ONE"},{"issue":"2","key":"650_CR55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4161\/hv.5.2.7210","volume":"5","author":"J Liu","year":"2009","unstructured":"Liu J, Tran V, Leung AS, Alexander DC, Zhu B. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum Vaccin. 2009;5(2):70\u20138.","journal-title":"Hum Vaccin"},{"issue":"9517","key":"650_CR56","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367(9517):1173\u201380.","journal-title":"Lancet"},{"issue":"8","key":"650_CR57","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.287.8.991","volume":"287","author":"MR Reichler","year":"2002","unstructured":"Reichler MR, Reves R, Bur S, Thompson V, Mangura BT, Ford J, et al. Evaluation of investigations conducted to detect and prevent transmission of tuberculosis. JAMA. 2002;287(8):991\u20135.","journal-title":"JAMA"},{"issue":"09","key":"650_CR58","first-page":"86","volume":"81","author":"WH Organization","year":"2006","unstructured":"Organization WH. The global plan to stop TB, 2006\u20132015: summary. Wkly Epidemiol Rec (Relev\u00e9 \u00e9pid\u00e9miologique Hebd). 2006;81(09):86\u20138.","journal-title":"Wkly Epidemiol Rec (Relev\u00e9 \u00e9pid\u00e9miologique Hebd)"},{"issue":"09","key":"650_CR59","first-page":"69","volume":"85","author":"WH Organization","year":"2010","unstructured":"Organization WH. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol Rec (Relev\u00e9 \u00e9pid\u00e9miologique hebd). 2010;85(09):69\u201379.","journal-title":"Wkly Epidemiol Rec (Relev\u00e9 \u00e9pid\u00e9miologique hebd)"},{"issue":"15","key":"650_CR60","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMcp1005750","volume":"364","author":"C Horsburgh","year":"2011","unstructured":"Horsburgh C, Rubin E. Supplement to: latent tuberculosis infection in the United States. N Engl J Med. 2011;364(15):1441\u20138.","journal-title":"N Engl J Med"},{"issue":"6","key":"650_CR61","doi-asserted-by":"crossref","first-page":"e1002321","DOI":"10.1371\/journal.pmed.1002321","volume":"14","author":"M Maheu-Giroux","year":"2017","unstructured":"Maheu-Giroux M, Vesga JF, Diabat\u00e9 S, Alary M, Baral S, Diouf D, et al. Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90\u201390\u201390 target in C\u00f4te d\u2019Ivoire: insights from mathematical modeling. PLoS Med. 2017;14(6):e1002321.","journal-title":"PLoS Med"},{"key":"650_CR62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijid.2016.03.003","volume":"46","author":"F Ntoumi","year":"2016","unstructured":"Ntoumi F, Kaleebu P, Macete E, Mfinanga S, Chakaya J, Yeboah-Manu D, et al. Taking forward the world TB day 2016 theme \u2018unite to end tuberculosis\u2019 for the WHO Africa region. Int J Infect Dis. 2016;46:34\u20137.","journal-title":"Int J Infect Dis"},{"issue":"Supplement_1","key":"650_CR63","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1086\/344657","volume":"36","author":"JB Nachega","year":"2003","unstructured":"Nachega JB, Chaisson RE. Tuberculosis drug resistance: a global threat. Clin Infect Dis. 2003;36(Supplement_1):S24\u201330.","journal-title":"Clin Infect Dis"},{"key":"650_CR64","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijid.2018.03.002","volume":"68","author":"S Tiberi","year":"2018","unstructured":"Tiberi S, Petersen E, Maeurer M, Ntoumi F, Yeboa-Manu D, Mwaba P, et al. Taking forward the stop TB partnership and world health organization joint theme for world TB day march 24th 2018\u2014\u201cwanted: leaders for a TB-free world. You can make history. End TB.\u201d Int J Infect Dis. 2018;68:122\u20134.","journal-title":"Int J Infect Dis"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-022-00650-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-022-00650-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T13:18:34Z","timestamp":1674739114000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-022-00650-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,12]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["650"],"URL":"https:\/\/doi.org\/10.1186\/s40001-022-00650-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1152198\/v1","asserted-by":"object"}]},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,12]]},"assertion":[{"value":"8 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol for patient recruitment and participation in the study followed the principles of the Declaration of Helsinki and was approved by the Dilla University Health Research Ethics Review Committee under the protocol unique number 005\/21-01. In the current study, socio-demographic and clinical data of TB suspected patients were collected retrospectively from medical records after getting permission to conduct the study from Dilla University referral hospital medical director and respective departments. Informed consent was not applicable for study participants since the study was retrospective and we have used the clinical data obtained from routine medical services. Strict confidentiality was maintained by removing all patient identifiers and only code numbers were used throughout the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}